1. Home
  2. DK vs LGND Comparison

DK vs LGND Comparison

Compare DK & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

N/A

Current Price

$74.25

Market Cap

3.4B

Sector

Energy

ML Signal

N/A

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

N/A

Current Price

$302.40

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DK
LGND
Founded
2001
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.7B
IPO Year
2017
1997

Fundamental Metrics

Financial Performance
Metric
DK
LGND
Price
$74.25
$302.40
Analyst Decision
Buy
Strong Buy
Analyst Count
13
11
Target Price
$76.77
★ $344.25
AVG Volume (30 Days)
★ 2.0M
210.4K
Earning Date
11-06-2026
11-05-2026
Dividend Yield
★ 1.33%
N/A
EPS Growth
95.67
★ 2886.36
EPS
N/A
★ 1.63
Revenue
N/A
★ $141,102,000.00
Revenue This Year
$33.50
$8.04
Revenue Next Year
N/A
$31.71
P/E Ratio
★ N/A
$180.98
Revenue Growth
N/A
★ 29.48
52 Week Low
$25.85
$175.89
52 Week High
$82.27
$326.63

Technical Indicators

Market Signals
Indicator
DK
LGND
Relative Strength Index (RSI) 53.70 56.38
Support Level $61.60 $276.71
Resistance Level $77.40 $320.45
Average True Range (ATR) 3.37 10.72
MACD 0.12 -0.43
Stochastic Oscillator 74.61 63.07

Price Performance

Historical Comparison
DK
LGND

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has three segments: Refining segment and Logistics segment and retail segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: